{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-066242","form_type":"8-K","ticker":"MD","cik":"0000893949","company_name":"Pediatrix Medical Group, Inc.","filed_at":"2024-05-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:22.344237+00:00","generated_at":"2026-06-01T07:33:22.818755+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Pediatrix Medical Group reiterates 2024 Adj. EBITDA guidance of $200M-$220M, portfolio optimization with $30M impact","bullets":["Company exiting office-based practices and primary/urgent care by end of 2024.","Annualized Adj. EBITDA impact of portfolio optimization ~$30M (based on 2023 results).","Reiterates 2024 Adj. EBITDA guidance range of $200M to $220M, including in-year impact.","Focus on operating efficiency and margin stabilization."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-066242","json":"https://secwatch.observer/filing/0000950170-24-066242.json","markdown":"https://secwatch.observer/filing/0000950170-24-066242.md","text":"https://secwatch.observer/filing/0000950170-24-066242.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/893949/000095017024066242/0000950170-24-066242-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/893949/000095017024066242/md-20240530.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T07:33:22.818755+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}